Bank of the West’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank of the West’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$355K	Sell	1,229 -38	-3%	-$11.6K	0.04%	187
2022 Q3	$367K	Buy	1,267 +41	+3%	+$11.8K	0.05%	174
2022 Q2	$345K	Sell	1,226 -34	-3%	-$9.1K	0.04%	181
2022 Q1	$329K	Sell	1,260 -38	-3%	-$9.02K	0.03%	188
2021 Q4	$285K	Sell	1,298 -269	-17%	-$52.3K	0.03%	204
2021 Q3	$284K	Sell	1,567 -61	-4%	-$11.9K	0.03%	202
2021 Q2	$328K	Sell	1,628 -2,506	-61%	-$524K	0.03%	193
2021 Q1	$888K	Sell	4,134 -324	-7%	-$71.2K	0.1%	134
2020 Q4	$1.05M	Buy	4,458 +90	+2%	+$20.6K	0.12%	122
2020 Q3	$1.19M	Sell	4,368 -2,216	-34%	-$611K	0.16%	108
2020 Q2	$1.91M	Sell	6,584 -319	-5%	-$86.5K	0.26%	88
2020 Q1	$1.64M	Sell	6,903 -1,012	-13%	-$232K	0.26%	94
2019 Q4	$1.73M	Sell	7,915 -63	-0.8%	-$12.8K	0.2%	107
2019 Q3	$1.35M	Buy	7,978 +340	+4%	+$60.1K	0.16%	121
2019 Q2	$1.4M	Sell	7,638 -12	-0.2%	-$2.1K	0.16%	126
2019 Q1	$1.41M	Sell	7,650 -11,064	-59%	-$2.04M	0.16%	131
2018 Q4	$3.36M	Buy	18,714 +9,226	+97%	+$1.6M	0.4%	73
2018 Q3	$1.83M	Buy	9,488 +596	+7%	+$106K	0.21%	119
2018 Q2	$1.51M	Buy	8,892 +792	+10%	+$123K	0.19%	136
2018 Q1	$1.32M	Buy	8,100 +1,304	+19%	+$213K	0.17%	150
2017 Q4	$1.02M	Buy	+6,796	New	+$1.01M	0.13%	156

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of the West's VRTX Position: Q4 2022 in Review

Bank of the West reduced its Vertex Pharmaceuticals (VRTX) stake by 3% in Q4 2022, selling an estimated $11.6K and leaving 1,229 shares worth $355K. The position accounts for 0.04% of the portfolio, ranked #187.

Bank of the West first reported a position in VRTX in Q4 2017 and has held it in 21 quarters since. The position peaked at $3.36M in Q4 2018. 1,223 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

Bank of the West held 1,229 shares of Vertex Pharmaceuticals worth $355K as of Q4 2022.
Bank of the West sold 38 Vertex Pharmaceuticals shares in Q4 2022, an estimated $11.6K.
Vertex Pharmaceuticals made up 0.04% of Bank of the West's portfolio in Q4 2022, its #187 holding.
Bank of the West first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 21 quarters since.
Bank of the West's Vertex Pharmaceuticals position peaked at $3.36M in Q4 2018.
1,223 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.